Apparel - Footwear & Accessories
Compare Stocks
5 / 10Stock Comparison
AREB vs STZ vs SAM vs CRBP vs SWKH
Revenue, margins, valuation, and 5-year total return — side by side.
Beverages - Wineries & Distilleries
Beverages - Alcoholic
Biotechnology
Asset Management
AREB vs STZ vs SAM vs CRBP vs SWKH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Apparel - Footwear & Accessories | Beverages - Wineries & Distilleries | Beverages - Alcoholic | Biotechnology | Asset Management |
| Market Cap | $123.00 | $26.05B | $2.18B | $136M | $192M |
| Revenue (TTM) | $10M | $9.38B | $2.09B | $0.00 | $41M |
| Net Income (TTM) | $-34M | $1.11B | $-61M | $-79M | $23M |
| Gross Margin | -2.1% | 52.0% | 45.2% | — | — |
| Operating Margin | -155.0% | 34.5% | -3.8% | — | 48.9% |
| Forward P/E | — | 12.7x | 20.6x | — | 7.6x |
| Total Debt | $2M | $12.11B | $38M | $2M | $32M |
| Cash & Equiv. | $148K | $68M | $223M | $28M | $43M |
AREB vs STZ vs SAM vs CRBP vs SWKH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| American Rebel Hold… (AREB) | 100 | 0.0 | -100.0% |
| Constellation Brand… (STZ) | 100 | 87.0 | -13.0% |
| The Boston Beer Com… (SAM) | 100 | 35.9 | -64.1% |
| Corbus Pharmaceutic… (CRBP) | 100 | 4.9 | -95.1% |
| SWK Holdings Corpor… (SWKH) | 100 | 156.1 | +56.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AREB vs STZ vs SAM vs CRBP vs SWKH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, AREB doesn't own a clear edge in any measured category.
STZ is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 4 yrs, beta 0.26, yield 2.7%
- 11.8% margin vs AREB's -360.5%
- 2.7% yield; 4-year raise streak; the other 4 pay no meaningful dividend
SAM ranks third and is worth considering specifically for growth exposure.
- Rev growth 3.7%, EPS growth 95.5%, 3Y rev CAGR -0.0%
- 3.7% revenue growth vs CRBP's -98.4%
CRBP is the clearest fit if your priority is momentum.
- +77.3% vs AREB's -100.0%
SWKH carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 164.3% 10Y total return vs STZ's 12.6%
- Lower volatility, beta 0.01, Low D/E 13.7%, current ratio 9.41x
- Beta 0.01, current ratio 9.41x
- Better valuation composite
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.7% revenue growth vs CRBP's -98.4% | |
| Value | Better valuation composite | |
| Quality / Margins | 11.8% margin vs AREB's -360.5% | |
| Stability / Safety | Beta 0.01 vs CRBP's 1.36 | |
| Dividends | 2.7% yield; 4-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +77.3% vs AREB's -100.0% | |
| Efficiency (ROA) | 7.3% ROA vs AREB's -155.5%, ROIC 5.1% vs -235.6% |
AREB vs STZ vs SAM vs CRBP vs SWKH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
AREB vs STZ vs SAM vs CRBP vs SWKH — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SWKH leads in 3 of 6 categories
SAM leads 1 • STZ leads 1 • AREB leads 0 • CRBP leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SWKH leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
STZ and CRBP operate at a comparable scale, with $9.4B and $0 in trailing revenue. STZ is the more profitable business, keeping 11.8% of every revenue dollar as net income compared to AREB's -3.6%. On growth, AREB holds the edge at +28.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $10M | $9.4B | $2.1B | $0 | $41M |
| EBITDAEarnings before interest/tax | -$15M | $3.7B | $14M | -$84M | $25M |
| Net IncomeAfter-tax profit | -$34M | $1.1B | -$61M | -$79M | $23M |
| Free Cash FlowCash after capex | -$14M | $1.8B | $191M | -$64M | $23M |
| Gross MarginGross profit ÷ Revenue | -2.1% | +52.0% | +45.2% | — | — |
| Operating MarginEBIT ÷ Revenue | -155.0% | +34.5% | -3.8% | — | +48.9% |
| Net MarginNet income ÷ Revenue | -3.6% | +11.8% | -2.9% | — | -6.1% |
| FCF MarginFCF ÷ Revenue | -150.8% | +18.8% | +9.1% | — | +65.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +28.5% | -9.8% | +1.7% | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +55.6% | -15.0% | -7.4% | -60.3% | +157.1% |
Valuation Metrics
Evenly matched — AREB and SWKH each lead in 2 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, SAM's 8.5x EV/EBITDA is more attractive than STZ's 9.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $123 | $26.1B | $2.2B | $136M | $192M |
| Enterprise ValueMkt cap + debt − cash | $2M | $38.1B | $2.0B | $109M | $182M |
| Trailing P/EPrice ÷ TTM EPS | 0.00x | -333.89x | 20.50x | -1.84x | -75.71x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.70x | 20.56x | — | 7.58x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 9.37x | 8.45x | — | 8.94x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 2.55x | 1.04x | — | 4.64x |
| Price / BookPrice ÷ Book value/share | 0.00x | 3.82x | 2.54x | 0.98x | 0.82x |
| Price / FCFMarket cap ÷ FCF | — | 13.44x | 10.09x | — | 7.05x |
Profitability & Efficiency
SAM leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
STZ delivers a 13.9% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-8 for AREB. CRBP carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to STZ's 1.70x. On the Piotroski fundamental quality scale (0–9), SAM scores 7/9 vs CRBP's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -7.8% | +13.9% | -7.3% | -65.8% | +8.4% |
| ROA (TTM)Return on assets | -155.5% | +5.1% | -5.0% | -57.9% | +7.3% |
| ROICReturn on invested capital | -2.4% | +13.0% | +15.5% | -51.4% | +5.1% |
| ROCEReturn on capital employed | -49.4% | +18.0% | +14.8% | -58.5% | +6.8% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 | 7 | 2 | 5 |
| Debt / EquityFinancial leverage | 0.52x | 1.70x | 0.04x | 0.01x | 0.14x |
| Net DebtTotal debt minus cash | $2M | $12.0B | -$186M | -$27M | -$11M |
| Cash & Equiv.Liquid assets | $147,586 | $68M | $223M | $28M | $43M |
| Total DebtShort + long-term debt | $2M | $12.1B | $38M | $2M | $32M |
| Interest CoverageEBIT ÷ Interest expense | -12.58x | 5.47x | — | — | 7.40x |
Total Returns (Dividends Reinvested)
SWKH leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SWKH five years ago would be worth $15,781 today (with dividends reinvested), compared to $0 for AREB. Over the past 12 months, CRBP leads with a +77.3% total return vs AREB's -100.0%. The 3-year compound annual growth rate (CAGR) favors SWKH at 13.8% vs SAM's -13.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -100.0% | +7.9% | +1.5% | +38.1% | -7.2% |
| 1-Year ReturnPast 12 months | -100.0% | -18.7% | -15.9% | +77.3% | +15.4% |
| 3-Year ReturnCumulative with dividends | -100.0% | -29.0% | -35.0% | +7.3% | +47.5% |
| 5-Year ReturnCumulative with dividends | -100.0% | -30.1% | -81.8% | -78.0% | +57.8% |
| 10-Year ReturnCumulative with dividends | -100.0% | +12.6% | +32.0% | -85.4% | +164.3% |
| CAGR (3Y)Annualised 3-year return | — | -10.8% | -13.4% | +2.4% | +13.8% |
Risk & Volatility
SWKH leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SWKH is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than CRBP's 1.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SWKH currently trades 88.8% from its 52-week high vs AREB's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.05x | 0.26x | 0.29x | 1.36x | 0.01x |
| 52-Week HighHighest price in past year | $127200.00 | $196.91 | $264.46 | $20.56 | $17.90 |
| 52-Week LowLowest price in past year | $0.07 | $126.45 | $185.34 | $6.10 | $13.32 |
| % of 52W HighCurrent price vs 52-week peak | +0.0% | +76.3% | +76.7% | +52.9% | +88.8% |
| RSI (14)Momentum oscillator 0–100 | 15.9 | 45.9 | 28.7 | 65.3 | 33.4 |
| Avg Volume (50D)Average daily shares traded | 2.9M | 1.8M | 199K | 262K | 17K |
Analyst Outlook
STZ leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: STZ as "Buy", SAM as "Hold", CRBP as "Buy", SWKH as "Buy". Consensus price targets imply 370.5% upside for CRBP (target: $51) vs 16.9% for STZ (target: $176). STZ is the only dividend payer here at 2.68% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $175.70 | $246.86 | $51.14 | — |
| # AnalystsCovering analysts | — | 46 | 31 | 14 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +2.7% | — | — | — |
| Dividend StreakConsecutive years of raises | — | 4 | 0 | — | — |
| Dividend / ShareAnnual DPS | — | $4.03 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +4.3% | +9.4% | 0.0% | 0.0% |
SWKH leads in 3 of 6 categories (Income & Cash Flow, Total Returns). SAM leads in 1 (Profitability & Efficiency). 1 tied.
AREB vs STZ vs SAM vs CRBP vs SWKH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AREB or STZ or SAM or CRBP or SWKH a better buy right now?
For growth investors, The Boston Beer Company, Inc.
(SAM) is the stronger pick with 3. 7% revenue growth year-over-year, versus -16. 6% for American Rebel Holdings, Inc. (AREB). The Boston Beer Company, Inc. (SAM) offers the better valuation at 20. 5x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate Constellation Brands, Inc. (STZ) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AREB or STZ or SAM or CRBP or SWKH?
On forward P/E, SWK Holdings Corporation is actually cheaper at 7.
6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AREB or STZ or SAM or CRBP or SWKH?
Over the past 5 years, SWK Holdings Corporation (SWKH) delivered a total return of +57.
8%, compared to -100. 0% for American Rebel Holdings, Inc. (AREB). Over 10 years, the gap is even starker: SWKH returned +164. 3% versus AREB's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AREB or STZ or SAM or CRBP or SWKH?
By beta (market sensitivity over 5 years), SWK Holdings Corporation (SWKH) is the lower-risk stock at 0.
01β versus Corbus Pharmaceuticals Holdings, Inc. 's 1. 36β — meaning CRBP is approximately 10357% more volatile than SWKH relative to the S&P 500. On balance sheet safety, Corbus Pharmaceuticals Holdings, Inc. (CRBP) carries a lower debt/equity ratio of 1% versus 170% for Constellation Brands, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AREB or STZ or SAM or CRBP or SWKH?
By revenue growth (latest reported year), The Boston Beer Company, Inc.
(SAM) is pulling ahead at 3. 7% versus -16. 6% for American Rebel Holdings, Inc. (AREB). On earnings-per-share growth, the picture is similar: The Boston Beer Company, Inc. grew EPS 95. 5% year-over-year, compared to -119. 4% for SWK Holdings Corporation. Over a 3-year CAGR, AREB leads at 6. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AREB or STZ or SAM or CRBP or SWKH?
The Boston Beer Company, Inc.
(SAM) is the more profitable company, earning 5. 2% net margin versus -360. 5% for American Rebel Holdings, Inc. — meaning it keeps 5. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SWKH leads at 48. 9% versus -155. 0% for AREB. At the gross margin level — before operating expenses — STZ leads at 51. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AREB or STZ or SAM or CRBP or SWKH more undervalued right now?
On forward earnings alone, SWK Holdings Corporation (SWKH) trades at 7.
6x forward P/E versus 20. 6x for The Boston Beer Company, Inc. — 13. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRBP: 370. 5% to $51. 14.
08Which pays a better dividend — AREB or STZ or SAM or CRBP or SWKH?
In this comparison, STZ (2.
7% yield) pays a dividend. AREB, SAM, CRBP, SWKH do not pay a meaningful dividend and should not be held primarily for income.
09Is AREB or STZ or SAM or CRBP or SWKH better for a retirement portfolio?
For long-horizon retirement investors, Constellation Brands, Inc.
(STZ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 26), 2. 7% yield). Both have compounded well over 10 years (STZ: +12. 6%, CRBP: -85. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AREB and STZ and SAM and CRBP and SWKH?
These companies operate in different sectors (AREB (Consumer Cyclical) and STZ (Consumer Defensive) and SAM (Consumer Defensive) and CRBP (Healthcare) and SWKH (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
STZ pays a dividend while AREB, SAM, CRBP, SWKH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.